“…gonorrhoeae, appear to have gradually built up intrinsic resistance over the years, and now seem about to become clinically resistant. Hejzlar & Vymola (1965) and Amies (1967) have indicated the alarming rise in the in vitro resistance of gonococci to benzylpenicillin recently, an increase paralleled by a rise in the failure rate for the single-dose treatment of gonorrhoea (Kjellander & Finland, 1963;Oller, 1967). As gonococci have not yet been shown to produce penicillinase, this increased resistance is another example of an in vivo selection of Class I11 mutants from a predominantly Class I population.…”